-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Mineralys Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2022 to 31 Dec 2025.
- Mineralys Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $45,487,000, a 138% decline year-over-year.
- Mineralys Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $142,416,000, a 14% increase from 2024.
- Mineralys Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $166,314,000, a 105% decline from 2023.
- Mineralys Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $81,173,000, a 178% decline from 2022.